New Therapeutic Options for the Maintenance of Remission of the Ulcerative Colitis in Pediatric Patients
Read time: 1 mins
Last updated:27th Mar 2013
The primary objective is to determine whether the addition of azathioprine to a standard therapeutic regimen (mesalazine and steroid association) improves disease remission rates in children affected by newly diagnosed moderate-to-severe Ulcerative Colitis, during the first eighteen months of treatment.
|Study start date||2013-03-27|